Cibc World Markets Corp Nuvalent, Inc. Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Nuvalent, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 3,288 shares of NUVL stock, worth $274,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,288Holding current value
$274,021% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
218Shares Held
59.7MCall Options Held
579KPut Options Held
745K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.67 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$417 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$344 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$252 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$248 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.58B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...